Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression

被引：14

作者：

Martínez-Castelao, A

Grinyó, JM

Gil-Vernet, S

Serón, D

Castiñeiras, MJ

Ramos, R

Alsina, J

机构：

[1] Univ Barcelona, Serv Nefrol, Hosp Bellvitge Principes Espana, CSUB, Barcelona, Spain

[2] Univ Barcelona, Dept Bioquim, Hosp Bellvitge Principes Espana, CSUB, Barcelona, Spain

来源：

TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 01期

关键词：

D O I：

10.1016/S0041-1345(01)02836-6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：398 / +

页数：4

共 18 条

[1] Treatment of hyperlipidemia in renal transplant recipients [J].

Arnadottir, M ;

Berg, AL .

TRANSPLANTATION, 1997, 63 (03) :339-345

[2]

Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599

[3]

BROWN MS, 1994, PRINCIPLES INTERNAL, P2058

[4]

CASTELAO AM, 1992, TRANSPLANT P, V24, P96

[5]

CASTELAO AM, 1993, TRANSPLANT P, V25, P1043

[6]

CASTELAO AM, 1995, TRANSPLANT P, V27, P2217

[7] Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine [J].

Goldberg, R ;

Roth, D .

TRANSPLANTATION, 1996, 62 (11) :1559-1564

[8]

HOFFMAN R, 1992, ATHEROSCLEROSIS, V41, P335

[9]

ILLINGWORTH DR, 1994, CLIN THER, V16, P336

[10]

KASISKE BL, 1994, KIDNEY INT, V45, pS51

← 1 2 →